GlassScriptPhysician profile
Justin Albani
NPI 1295777464
$4,283.70
in general payments reported to CMS, 2019-2025
36 companies · $465 in 2025
The $465 reported for 2025 was more than what 77% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $858 · 2020: $399 · 2021: $645 · 2022: $878 · 2023: $741 · 2024: $297 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,403 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,403.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $859.75 | 2019-2024 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $392.73 | 2019-2022 | |
| Procept Biorobotics Corporation | $389.78 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Abbvie INC. | $367.24 | 2019-2025 | Lupron Depot, Botox |
| Antares Pharma, INC. | $267.02 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Olympus America INC. | $201.81 | 2019-2025 | Itind System, Soltive |
| 180 Medical, INC. | $191.81 | 2019-2023 | Gentlecath |
| Blue Earth Diagnostics | $179.10 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $134.29 | 2025 | |
| Karl Storz Endoscopy-America | $124.21 | 2022-2023 | Flex-X |
| Rochester Medical Corporation | $109.57 | 2020 | |
| Convatec INC. | $105.10 | 2019-2022 | |
| Pfizer INC. | $96.23 | 2019-2025 | |
| Boston Scientific Corporation | $94.80 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700 |
| Urovant Sciences INC | $85.69 | 2021-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $79.32 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $70.14 | 2021 | |
| Amgen INC. | $68.58 | 2019-2021 | |
| Zyla Life Sciences, INC. | $57.57 | 2019 | |
| Endo Pharmaceuticals INC. | $57.55 | 2022-2023 | Xiaflex |
| Coloplast Corp | $38.89 | 2023 | Porges Coloplast |
| Ferring Pharmaceuticals INC. | $35.50 | 2019 | |
| Sumitomo Pharma America, INC. | $30.36 | 2024 | Gemtesa |
| Immunitybio, INC. | $29.81 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $23.69 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.21 | 2024 | |
| Endo USA, INC. | $22.62 | 2025 | Xiaflex |
| Axonics, INC. | $21.40 | 2023 | Axonics |
| Urogen Pharma, INC. | $20.93 | 2025 | |
| Allergan, INC. | $19.14 | 2019 | |
| Agiliti Surgical, INC. | $16.61 | 2019 | |
| Halozyme INC | $15.68 | 2023 | |
| Photocure INC | $14.06 | 2023 | Cysview |
| Kowa Pharmaceuticals America, INC. | $13.33 | 2022 | |
| Intuitive Surgical, INC. | $13.20 | 2020 | |
| Myovant Sciences INC. | $12.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Albani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.